Synthesis and antitumor activity evaluation of 1-[ (arylidene) amino]adamantanes

Chimirri, A.; Gitto, R.; Grasso, S.; Monforte, A.M.; Zappalà, M.

Farmaco 49(10): 649-651

1994


ISSN/ISBN: 0014-827X
PMID: 7826471
Document Number: 424185
Several 1-[(arylidene)amino]adamantanes were synthesized and evaluated in vitro as antitumor agents against 60 human tumor cell lines. Some of these derivatives showed specificity for human leukemia cell lines and 1-[(2-bromobenzylidene)amino]adamantane (2) (NSC 631076-L), the most active compound, was selected by the Biological Evaluation Committee (BEC), for in vivo testing.

Document emailed within 1 workday
Secure & encrypted payments